Patents by Inventor Pedro Antonio Lopez Saura

Pedro Antonio Lopez Saura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
    Publication number: 20170119733
    Abstract: The present invention describes peptides comprising phycocyanobilin (PCB), as well as the medical use of said peptides and that of PCB, due to the neuroprotector and/or neuroregenerative effects identified for them. Furthermore, pharmaceutical combinations of said peptides and of PCB with proteins or other peptides with synergic effect justify their use for ischemic or neurodegenerative CNS disease treatment.
    Type: Application
    Filed: November 10, 2016
    Publication date: May 4, 2017
    Inventors: Giselle Penton Rol, Alexey Llopiz Arzuaga, Javier Marin Prida, Eduardo Penton Arias, Efrain Rodriguez Jimenez, Alexis Musacchio Lasa, Vladimir Armando Besada Perez, Gilberto Lazaro Pardo Andreu, Luis Javier Gonzalez Lopez, Nancy Pavon Fuentes, Gerardo Enrique Guillen Nieto, Pedro Antonio Lopez Saura
  • Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
    Patent number: 9518085
    Abstract: The present invention describes peptides comprising phycocyanobilin (PCB), as well as the medical use of said peptides and that of PCB, due to the neuroprotector and/or neuroregenerative effects identified for them. Furthermore, pharmaceutical combinations of said peptides and of PCB with proteins or other peptides with synergic effect justify their use for ischemic or neurodegenerative CNS disease treatment.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: December 13, 2016
    Assignee: CENTRO DE INGENIERÍA GENÉTICA Y BIOTECHNOLOGÍA
    Inventors: Giselle Penton Rol, Alexey Llopiz Arzuaga, Javier Marin Prida, Eduardo Penton Arias, Efrain Rodriguez Jimenez, Alexis Musacchio Lasa, Vladimir Armando Besada Perez, Gilberto Lazaro Pardo Andreu, Luis Javier Gonzalez Lopez, Nancy Pavon Fuentes, Gerardo Enrique Guillen Nieto, Pedro Antonio Lopez Saura
  • Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
    Publication number: 20140356319
    Abstract: The present invention describes peptides comprising phycocyanobilin (PCB), as well as the medical use of said peptides and that of PCB, due to the neuroprotector and/or neuroregenerative effects identified for them. Furthermore, pharmaceutical combinations of said peptides and of PCB with proteins or other peptides with synergic effect justify their use for ischemic or neurodegenerative CNS disease treatment.
    Type: Application
    Filed: June 29, 2012
    Publication date: December 4, 2014
    Applicant: CENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA
    Inventors: Giselle Penton Rol, Alexey Llopiz Arzuaga, Javier Marin Prida, Eduardo Pentón Arias, Efraín Rodríguez Jiménez, Alexis Musacchio Lasa, Vladimir Armando Besada Perez, Gilberto Lázaro Pardo Andreu, Luis Javier González López, Nancy Pavón Fuentes, Gerardo Enrique Guillen Nieto, Pedro Antonio López Saura
  • Treatment of multiple sclerosis by administration of interferon alpha and C-phycocyanin
    Patent number: 8110182
    Abstract: The present invention consists of the combination of Interferon alpha and C-Phycocyanin (IFN-?/C-Phyco) for obtaining a pharmaceutical preparation for autoimmune disease, allergy and cancer treatments. The anti-inflammatory, immunomodulator, antioxidant, anti-viral, anti-proliferative and anti-tumoral effects, associated to the regulatory T cell inducer effect demonstrated in this invention is the rationale for the use of the IFN-?/C-Phyco combination in these diseases.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: February 7, 2012
    Assignee: Centro de Ingenieria Genectica y Biotecnologia
    Inventors: Giselle Penton Rol, Majel Cervantes Llanos, Eduardo Penton Arias, Diana Garcia del Barco Herrera, Carmen Maria Valenzuela Silva, Pedro Antonio Lopez Saura, Gerardo Enrique Guillen Nieto
  • Interferon AlPha And C-Phycocyanin For The Treatment Of Autoimmune Diseases, Allergy And Cancer
    Publication number: 20090280087
    Abstract: The present invention consists of the combination of Interferon alpha and C-Phycocyanin (IFN-?/C-Phyco) for obtaining a pharmaceutical preparation for autoimmune disease, allergy and cancer treatments. The anti-inflammatory, immunomodulator, antioxidant, anti-viral, anti-proliferative and anti-tumoral effects, associated to the regulatory T cell inducer effect demonstrated in this invention is the rationale for the use of the IFN-?/C-Phyco combination in these diseases.
    Type: Application
    Filed: October 30, 2006
    Publication date: November 12, 2009
    Inventors: Giselle Penton Rol, Majel Cervantes Llanos, Eduardo Penton Arias, Diana Garcia del Barco Herrera, Carmen Maria Valenzuela Silva, Pedro Antonio Lopez Saura, Gerardo Enrique Guillen Nieto